Current Liabilities
Accrued Manufacturing Costs
Moderna Accrued Manufacturing Costs decreased by 74.3% to $108.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.0%, from $120.00M to $108.00M. Over 5 years (FY 2020 to FY 2025), Accrued Manufacturing Costs shows an upward trend with a 34.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
Metric ID:
accrued_manufacturing_costsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.00M | $105.00M | $126.00M | $74.00M | $128.00M | $141.00M | $190.00M | $73.00M | $126.00M | $251.00M | $245.00M | $95.00M | $187.00M | $244.00M | $312.00M | $120.00M | $197.00M | $310.00M | $420.00M | $108.00M |
| QoQ Change | — | +69.4% | +20.0% | -41.3% | +73.0% | +10.2% | +34.8% | -61.6% | +72.6% | +99.2% | -2.4% | -61.2% | +96.8% | +30.5% | +27.9% | -61.5% | +64.2% | +57.4% | +35.5% | -74.3% |
| YoY Change | — | — | — | — | +106.5% | +34.3% | +50.8% | -1.4% | -1.6% | +78.0% | +28.9% | +30.1% | +48.4% | -2.8% | +27.3% | +26.3% | +5.3% | +27.0% | +34.6% | -10.0% |
Range$62.00M – $420.00M
CAGR+12.4%
Avg YoY Growth+30.1%
Median YoY Growth+28.1%
Accrued Manufacturing Costs at Other Companies
Frequently Asked Questions
- What is Moderna's accrued manufacturing costs?
- Moderna (MRNA) reported accrued manufacturing costs of $108.00M in Q1 2026.
- How has Moderna's accrued manufacturing costs changed year-over-year?
- Moderna's accrued manufacturing costs decreased by 10.0% year-over-year, from $120.00M to $108.00M.
- What is the long-term trend for Moderna's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Moderna's accrued manufacturing costs has grown at a 34.6% compound annual growth rate (CAGR), from $95.00M to $420.00M.